May 01, 2025 a 05:00 pm
CNC: Analysts Ratings - Centene Corporation
Centene Corporation, a prominent player in the healthcare sector, shows a varied mix of analyst ratings over recent months. The ratings have been relatively stable, with a slight shift towards increased caution among analysts. With strong buy recommendations largely unchanged, there is a notable increase in hold ratings, suggesting a more cautious outlook.
Historical Stock Grades
Recent analyst ratings for Centene Corporation have shown a consistent trend, with a strong presence in the 'Hold' category. While 'Strong Buy' and 'Buy' remain steady, the increase in 'Hold' suggests analysts are adopting a watchful stance.
| Recommendation | Number | Score |
|---|---|---|
| Strong Buy | 4 | |
| Buy | 7 | |
| Hold | 9 | |
| Sell | 1 | |
| Strong Sell | 0 |
Sentiment Development
- The overall number of ratings remains stable, but with a slight shift from 'Buy' to 'Hold'.
- 'Strong Buy' ratings have been stable, whereas 'Hold' ratings have increased, indicating more conservative analyst perspectives.
- There is no significant increase in 'Sell' or 'Strong Sell', indicating no prevalent negative sentiment.
Percentage Trends
Analysts' recommendations reflect a cautious sentiment with a slight migration from 'Buy' towards 'Hold'. This suggests a careful outlook on the stock amidst market uncertainties.
- The portion of 'Hold' recommendations has risen while 'Strong Buy' has remained stable.
- This transition suggests more analysts are taking a neutral stance.
- In the last 6-12 months, 'Strong Buy' ratings have decreased from 6 to 4, and 'Hold' increased notably.
Latest Analyst Recommendations
Recent analyst actions reflect minimal changes in opinions with several rating supports. The only upgrade observed was a shift from 'Underperform' to 'Hold'.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-04-29 | Hold | Hold | Jefferies |
| 2025-04-29 | Neutral | Neutral | Guggenheim |
| 2025-04-28 | Overweight | Overweight | Barclays |
| 2025-04-15 | Neutral | Neutral | Baird |
| 2025-04-08 | Hold | Underperform | Jefferies |
Analyst Recommendations with Change of Opinion
Following recent rating changes, a few notable shifts include upgrades from 'Underperform' to 'Hold' and 'Neutral' to 'Buy', indicating differing analyst perspectives. Several downgrades also signal caution in future growth potential.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-04-08 | Hold | Underperform | Jefferies |
| 2024-12-13 | Buy | Neutral | UBS |
| 2024-12-10 | Underperform | Hold | Jefferies |
| 2024-07-24 | Hold | Buy | Jefferies |
| 2024-03-25 | Equal Weight | Overweight | Stephens & Co. |
Interpretation
Analyst sentiment identifies Centene Corporation with a cautious market outlook. Stable recommendations amidst market fluctuation suggest analysts are preserving a neutral stance. Although some upgrades and downgrades hint at diverse opinions, the lack of significant negative recommendations suggests moderate confidence in the stock’s stability.
Conclusion
Centene Corporation's stock ratings depict equilibrium between cautious optimism and market uncertainty. With strong buy recommendations remaining unchanged, the increase in hold ratings points to analysts' careful perspective amidst potential market fluctuations. Although recent upgrades and downgrades display contrasting sentiments, overall stabilization in analysts' views indicates a balanced approach to market challenges for the upcoming period.